Outcome measures in systemic sclerosis: An update on instruments and current research
作者： Dinesh Khanna , Peter A. Merkel
DOI: 10.1007/S11926-007-0010-5
关键词:
摘要: Substantial progress has been made in the past 10 years development and validation of outcome measures refinement trial methodology for systemic sclerosis (scleroderma, SSc). These advances have focused mostly on specific organ systems involved SSc. Many these new tools validated subsequently adapted use multicenter clinical trials. Newer are intended to more precisely quantify clinically meaningful change systems, some methods aim assess overall disease burden This review provides an update currently used SSc with attention newer also describes under development.
springer.com
sci-hub.se 参考文章(57)
P Brooks, M Boers, C V Strand, P Tugwell, The OMERACT filter for Outcome Measures in Rheumatology. The Journal of Rheumatology. ,vol. 25, pp. 198- 199 ,(1998)
GERALD SIMONNEAU, ROBYN J. BARST, NAZZARENO GALIE, ROBERT NAEIJE, STUART RICH, ROBERT C. BOURGE, ANNE KEOGH, RONALD OUDIZ, ADAANI FROST, SHELMER D. BLACKBURN, JAMES W. CROW, LEWIS J. RUBIN, Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. American Journal of Respiratory and Critical Care Medicine. ,vol. 165, pp. 800- 804 ,(2002) , 10.1164/AJRCCM.165.6.2106079
Sabina A Antoniu, Cyclophosphamide for scleroderma interstitial lung disease Expert Opinion on Investigational Drugs. ,vol. 16, pp. 393- 395 ,(2007) , 10.1517/13543784.16.3.393
John D. Reveille, Daniel E. Furst, Maria E. Suarez-Almazor, Philip J. Clements, Gabriele Valentini, Peter A. Merkel, Current Status of Outcome Measure Development for Clinical Trials in Systemic Sclerosis. Report from OMERACT 6 The Journal of Rheumatology. ,vol. 30, pp. 1630- 1647 ,(2003)
Dinesh Khanna, Daniel E Furst, Philip J Clements, Grace S Park, Ron D Hays, Jeonglim Yoon, Joseph H Korn, Peter A Merkel, Naomi Rothfield, Fredrick M Wigley, Larry W Moreland, Richard Silver, Virginia D Steen, Michael Weisman, Maureen D Mayes, David H Collier, Thomas A Medsger, James R Seibold, Relaxin Study Group, Scleroderma Clinical Trials Consortium, Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a Systemic Sclerosis Clinical Trial The Journal of Rheumatology. ,vol. 32, pp. 832- 840 ,(2005)
Maureen D. Mayes, Daniel O'Donnell, Naomi F. Rothfield, M. E. Csuka, Minocycline is not effective in systemic sclerosis: Results of an open-label multicenter trial Arthritis & Rheumatism. ,vol. 50, pp. 553- 557 ,(2004) , 10.1002/ART.20036
Dinesh Khanna, Ron D. Hays, Grace S. Park, Yolanda Braun-Moscovici, Maureen D. Mayes, Terry A. McNearney, Vivien Hsu, Philip J. Clements, Daniel E. Furst, Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument Arthritis Care and Research. ,vol. 57, pp. 1280- 1286 ,(2007) , 10.1002/ART.22987
Edward Kasarskis, Disease-modifying interventions. Amyotrophic Lateral Sclerosis. ,vol. 5, pp. 76- 78 ,(2004) , 10.1080/17434470410019816
Peter A. Merkel, Nancy P. Silliman, Christopher P. Denton, Daniel E. Furst, Dinesh Khanna, Paul Emery, Vivien M. Hsu, James B. Streisand, Richard P. Polisson, Anita Åkesson, John Coppock, Frank van den Hoogen, Ariane Herrick, Maureen D. Mayes, Douglas Veale, James R. Seibold, Carol M. Black, Joseph H. Korn, , , Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial Arthritis Care and Research. ,vol. 59, pp. 699- 705 ,(2008) , 10.1002/ART.23564
Tsutomu HORIKOSHI, Tsutomu MATSUZAKI, Toshikazu SEKIGUCHI, Effect of H2-receptor antagonists cimetidine and famotidine on interdigestive gastric motor activity and lower esophageal sphincter pressure in progressive systemic sclerosis. Internal Medicine. ,vol. 33, pp. 407- 412 ,(1994) , 10.2169/INTERNALMEDICINE.33.407